Bar Harbor BioTechnology
Bar Harbor BioTechnology, Inc. is a privately held company founded in 2006 and located in the downeast section of Maine. The company launched its flagship products, GeneSieve™, StellARray™ and Global Pattern Recognition™ in 2007. The StellARray™ and XenoQ™ systems are distributed by Lonza Corporation under an exclusive global distribution agreement that was created in 2008. The StellARray™ system was recently used to identify a drug that shows the reversal of Type 1 Diabetes in mouse models.